ABEO Stock Analysis: Buy, Sell, or Hold?
ABEO - Abeona Therapeutics Inc. Common Stock
$6.21
0.15 (2.48%)
▲
5d:
+0.81%
30d:
+1.31%
90d:
+13.11%
WAIT
LOW Confidence
Analysis Updated: Aug 25, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When ABEO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ABEO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ABEO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ABEO is currently trading at $6.21, which is considered oversold relative to its 30-day fair value range of $6.12 to $7.09. From a valuation perspective, the stock is trading at a discount (Forward PE: -33.3) compared to its historical average (21.7). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ABEO is in a strong uptrend. Immediate support is located at $5.70, while resistance sits at $7.54.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.86 (+203.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABEO is in a strong uptrend. Immediate support is located at $5.70, while resistance sits at $7.54.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.86 (+203.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.12 -
$7.09
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 203.7% below Wall St target ($18.86)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$6.12 -
$7.09
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.70
Resistance Level
$7.55
Current Trend
Strong Uptrend
Technical data as of
Aug 25, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-33.26
Wall Street Target
$18.86
(+203.7%)
Revenue Growth (YoY)
2745.0%
Profit Margin
-246.4%
PE vs Historical
-33.3 vs 21.7
CHEAP
Share & Embed Analysis
Last updated: August 26, 2026 5:11 AM ET
Data refreshes hourly during market hours. Next update: 6:11 AM
Data refreshes hourly during market hours. Next update: 6:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABEO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 39 SELL |
|
EYPT
EyePoint, Inc |
STRONG BUY
13 analysts |
$27 | 52 HOLD |
